home / stock / xair / xair articles

XAIR Articles, Beyond Air Inc. - From 12/20/23

Stock Information
Company Name: Beyond Air Inc.
Stock Symbol: XAIR
Market: NYSE
Website: beyondair.net
Menu
XAIR XAIR Quote XAIR Short XAIR News XAIR Articles XAIR Message Board
Get XAIR Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Aclarion, Inc. (NASDAQ: ACON) shares rose sharply in pre-market trading after the company was granted U.S. patent #11844601 for "MR...
Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference | Benzinga

GARDEN CITY, N.Y., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company") a commercial stage medical d...

Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results. Shapeways Hldgs posted an ad...

Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. Beyond Air posted a quarterly lo...
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket | Benzinga

INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter. INVO Biosc...

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024 | Benzinga

Provides fiscal year 2025 revenue guidance of $12 - $16 million US pilot trial of LungFit® PRO to treat viral community acquired pneumonia (V...

Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting | Benzinga

First-in-human Phase 1 study demonstrates early clinical proof of concept Positive clinical biomarker data demonstrate evidence of immune system a...
Beyond Air® To Participate in the Truist Securities BioPharma Symposium | Benzinga

GARDEN CITY, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company") a commercial stage medical d...

Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PH | Benzinga

GARDEN CITY, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company"), a commercial stage medical ...

Beyond Air® To Participate in the Roth MKM 2023 Healthcare Opportunities Conference | Benzinga

GARDEN CITY, N.Y., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company") a commercial stage medical d...
Previous 10 Next 10